Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amphotericin B aerosol prophylaxis in GVHD patients on steroids
2008-003005-14Phase 2Terminated
- Sponsor
- Associazione Malattie del Sangue
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of amphotericin b in graft-versus-host disease (GVHD) and invasive mycoses, sponsored by Associazione Malattie del Sangue. Primary endpoint: Efficacy in decreasing invasive fungal infection rate. Started Jun 2008; status: terminated.
02
Drugs
amphotericin b
03
Conditions
graft-versus-host disease (GVHD)invasive mycoses
Beyond the preview
Go deeper on 2008-003005-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003005-14.